CA2871350A1 - Method for identifying agents capable of inducing respiratory sensitization and array and analytical kits for use in the method - Google Patents

Method for identifying agents capable of inducing respiratory sensitization and array and analytical kits for use in the method Download PDF

Info

Publication number
CA2871350A1
CA2871350A1 CA2871350A CA2871350A CA2871350A1 CA 2871350 A1 CA2871350 A1 CA 2871350A1 CA 2871350 A CA2871350 A CA 2871350A CA 2871350 A CA2871350 A CA 2871350A CA 2871350 A1 CA2871350 A1 CA 2871350A1
Authority
CA
Canada
Prior art keywords
expression
cells
include measuring
binding
respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2871350A
Other languages
English (en)
French (fr)
Inventor
Malin Lindstedt
Carl Borrebaeck
Henrik Johansson
Ann-Sofie Albrekt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SenzaGen AB
Original Assignee
SenzaGen AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SenzaGen AB filed Critical SenzaGen AB
Publication of CA2871350A1 publication Critical patent/CA2871350A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA2871350A 2012-04-26 2013-04-26 Method for identifying agents capable of inducing respiratory sensitization and array and analytical kits for use in the method Abandoned CA2871350A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201207297A GB201207297D0 (en) 2012-04-26 2012-04-26 Analytical methods and arrays for use in the same
GB1207297.1 2012-04-26
PCT/IB2013/053321 WO2013160882A1 (en) 2012-04-26 2013-04-26 Method for identifying agents capable of inducing respiratory sensitization and array and analytical kits for use in the method.

Publications (1)

Publication Number Publication Date
CA2871350A1 true CA2871350A1 (en) 2013-10-31

Family

ID=46261886

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2871350A Abandoned CA2871350A1 (en) 2012-04-26 2013-04-26 Method for identifying agents capable of inducing respiratory sensitization and array and analytical kits for use in the method

Country Status (10)

Country Link
US (2) US20150111771A1 (https=)
EP (1) EP2841599A4 (https=)
KR (1) KR20150016523A (https=)
CN (1) CN104685067A (https=)
BR (1) BR112014026582A2 (https=)
CA (1) CA2871350A1 (https=)
GB (1) GB201207297D0 (https=)
HK (1) HK1211059A1 (https=)
IN (1) IN2014MN02397A (https=)
WO (1) WO2013160882A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201421207D0 (en) * 2014-11-28 2015-01-14 Senzagen Ab Analytical methods and arrays for use in the same
GB201700138D0 (en) 2017-01-05 2017-02-22 Senzagen Ab Analytical methods and arrays for use in the same
JP7023857B2 (ja) * 2016-03-23 2022-02-22 センソシェン アクティエ ボラーグ 解析方法およびそれに用いるアレイ
TWI793151B (zh) 2017-08-23 2023-02-21 瑞士商諾華公司 3-(1-氧異吲哚啉-2-基)之氫吡啶-2,6-二酮衍生物及其用途
GB201715445D0 (en) 2017-09-25 2017-11-08 Senzagen Ab Novel cell line and uses thereof
CN109828113A (zh) * 2017-11-23 2019-05-31 复旦大学附属肿瘤医院 PAPSS1在制备筛选α干扰素治疗肝癌敏感人群标志物的制剂中的用途
CN108304912B (zh) * 2017-12-29 2020-12-29 北京理工大学 一种运用抑制信号实现脉冲神经网络监督学习的系统和方法
AR116109A1 (es) 2018-07-10 2021-03-31 Novartis Ag Derivados de 3-(5-amino-1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos
DK3820573T3 (da) 2018-07-10 2023-10-23 Novartis Ag 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidin-2,6-dion-derivativer og anvendelse deraf ved behandling af ikaros family zinc finger 2 (ikzf2)-afhængige sygdomme
WO2020141204A2 (en) 2019-01-03 2020-07-09 Senzagen Ab Analytical methods and arrays for use in the same
EP4130739A4 (en) * 2020-03-25 2023-06-14 FUJIFILM Corporation METHOD FOR MEASUREMENT OF RESPIRATORY SENSITIZATION AND REAGENT FOR MEASUREMENT OF RESPIRATORY SENSITIZATION
CN111596067B (zh) * 2020-06-03 2021-06-22 四川大学华西第二医院 Zc3h8在pop早期预警、诊断、预后评估中的应用和产品
CA3222964A1 (en) * 2021-07-02 2023-01-05 Regeneron Pharmaceuticals, Inc. Methods of treating asthma with solute carrier family 27 member 3 (slc27a3) inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
CA2608167C (en) * 2005-05-12 2012-05-01 Corporation Nuvolt Inc. Current sensor
EP1905843A1 (en) * 2006-09-29 2008-04-02 Vlaamse Instelling voor Technologisch Onderzoek Method for determining the allergic potential of a compound
US20090029868A1 (en) * 2006-10-31 2009-01-29 Applera Corporation Expression signature in peripheral blood for detection of aortic aneurysm
GB201018014D0 (en) 2010-10-26 2010-12-08 Senzagen Ab Analytical methods and arrays for use in the same

Also Published As

Publication number Publication date
EP2841599A1 (en) 2015-03-04
US20170283874A1 (en) 2017-10-05
IN2014MN02397A (https=) 2015-08-21
GB201207297D0 (en) 2012-06-06
BR112014026582A2 (pt) 2017-06-27
WO2013160882A1 (en) 2013-10-31
KR20150016523A (ko) 2015-02-12
HK1211059A1 (en) 2016-05-13
US20150111771A1 (en) 2015-04-23
CN104685067A (zh) 2015-06-03
EP2841599A4 (en) 2015-12-30

Similar Documents

Publication Publication Date Title
US20150111771A1 (en) Method for Identifying Agents Capable of Inducing Respiratory Sensitization and Array and Analytical Kits for Use in the Method
US20210189497A1 (en) Analytical methods and arrays for use in the same
US20170285010A1 (en) Analytical Methods and Arrays for Use in the Same
ES2913755T3 (es) Métodos analíticos y matrices para uso en los mismos
JP7590970B2 (ja) 分析方法およびそれにおいて使用するためのアレイ
HK40024606B (en) Analytical methods and arrays for use in the same
HK1189245B (en) Analytical methods and arrays for use in the identification of agents inducing sensitization in human skin

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20190426